Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$430,257,947
+$20,712,992 QoQ
Shares Held
1,188,164
+2.1% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#53
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Dec 31, 2024CallValue
$234,576
CallShares
900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. AMGN ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in AMGN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $430,257,947 | 1,188,164 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $409,544,955 | 1,163,976 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $387,257,481 | 1,183,152 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $322,262,240 | 1,141,964 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $279,450,399 | 1,000,861 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $281,603,190 | 903,878 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $215,638,418 | 827,342 | Shares | Sole | 2025-02-11 | |
| 2024-12-31 | $234,576 | 900 | Call | Sole | 2025-02-11 | |
| 2024-09-30 | $242,284,198 | 751,945 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $233,383,277 | 746,946 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $193,327,080 | 679,963 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $213,973,514 | 742,912 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $203,238,730 | 756,209 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $156,821,162 | 706,338 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $150,390,015 | 622,089 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $149,313,991 | 568,512 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $129,109,796 | 572,803 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $126,496,779 | 519,921 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $115,639,533 | 478,205 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $101,873,165 | 452,830 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $91,934,974 | 432,330 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $104,307,693 | 427,929 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $101,984,979 | 409,891 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $89,758,008 | 390,388 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $89,615,799 | 352,596 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $79,054,139 | 335,174 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $63,741,352 | 314,415 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||